Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents

Journal of Pharmacology and Experimental Therapeutics

Volumn 295, Issue 3, 2000, Pages 1267-1275

  Spooren, Will P J M ^a   Vassout, Annick ^a   Neijt, Hans C ^a   Kuhn, Rainer ^a   Gasparini, Fabrizio ^a   Roux, Silvain ^b   Porsolt, Roger D ^b   Gentsch, Conrad ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

^b Porsolt and Partners Pharmacology   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; DEXAMPHETAMINE; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONDITIONED REFLEX; CONTROLLED STUDY; DOSE RESPONSE; FOREBRAIN; HYPERTHERMIA; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEDATION; SOCIAL BEHAVIOR; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; BODY TEMPERATURE; DEXTROAMPHETAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; MALE; MAZE LEARNING; MICE; MOTOR ACTIVITY; PYRIDINES; RATS; RATS, INBRED BN; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 0033680311     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. The functional anatomy of basal ganglia disorders
2. Major tranquillizers can be distinguished from minor tranquilizers on the basis of effects on marble burying and swim-induced grooming in mice
3. Basal ganglia and movement disorders; an update
4. Pharmacology and functions of metabotropic glutamate receptors
5. Glutamate in CNS disorders
6. Effects of combined treatment with trifluoperazine-HCL and amobarbital on punished behavior in rats
7. Neuroanatomical characterization of FOS induction in rat behavioral models of anxiety
8. 2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
9. The effects of meprobromate, barbiturates, d-amphetamine and promazine on experimentally induced conflict in the rat
10. Effects of alpha-adrenocepter agonists and antagonists in a maze exploration model of 'fear'-motivated behaviour
11. Metabotropic glutamate receptors: Novel targets for drug development
12. F 11440, a potent, selective, high efficacy 5-HT(1A) receptor agonist with marked anxiolytic and antidepressant potential
13. Pharmacological validation of a novel animal model of anticipatory anxiety in mice
14. The excitatory amino acid receptors: Their classes, pharmacology, and distinct properties in the function of the central nervous system
15. Metabotropic glutamate receptors: A new target for the therapy of neurodegenerative disorders
16. 5HT3 Receptor antagonists and anxiety; a preclinical and clinical review
17. The metabotropic glutamate receptors: Structure and functions
18. Endogenous hyperthermia in normal human subjects: Experimental study of emotional states (II)
19. Animal models of 'anxiety' where next?
20. Anxiety, defense and the elevated plus-maze
21. Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain
22. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the brain
23. 5 receptor antagonist 2-methyl-6-(phenylethyl)-pyridine (MPEP) on motor behaviour: Rotarod, locomotor activity and rotational responses in the unilateral 6-OHDA-lesioned rat
24. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat
25. SIB-1757 and SIB-1893: Selective, non-competitive antagonists of metabotropic glutamate receptor type 5 (mGluR5)
26. Selective blockade of peripheral mGlu5 receptors offers a novel and effective relief of inflammatory pain
27. mGlu5 Receptors and nociceptive function. II. mGlu5 Receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia